Autori: Yardley Denise A
Naslov | Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2). (Meeting Abstract) |
Autori | Goel Shom O'Shaughnessy Joyce Tan Antoinette R Milev-Krastev Boris Rugo Hope S Aftimos Philippe Georges Yardley Denise A Andric Zoran G Wolfgang Curt Douglas Sorrentino Jessica Tao Wenli Beelen Andrew Paul Malik Rajesh K Jain Sarika |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. - |
Projekat | G1 Therapeutics, Inc |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|